A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2001
11/29/2001	US20010046474 Stabilized preparations for use in metered dose inhalers
11/29/2001	US20010046471 Infrared thermograpy and methods of use
11/29/2001	CA2409603A1 System and method for assessing the performance of a pharmaceutical agent delivery system
11/29/2001	CA2408315A1 Aminoacyl trna synthetases
11/29/2001	CA2408140A1 G-protein coupled receptors
11/28/2001	EP1156834A2 Assay for emetic activity
11/28/2001	EP1156833A1 Metastasis models using green fluorescent protein (gfp) as a marker
11/28/2001	EP0853483A4 Novel peptides
11/28/2001	CN1075388C Cascale polymers with iodine aromatic compounds
11/27/2001	US6323925 Apparatus for fabricating an orientation layer on LCD panels
11/27/2001	US6323175 Composition comprising physiologically compatible liposome, hemoglobin encapsulated in liposome, and nitroxide encapsulated in liposome
11/27/2001	US6323038 Diagnostic reagent for complications associated with diabetes or renal failure
11/27/2001	US6322771 Parenterally administering to a mammal a purine derivative to diagnose coronary artery stenosis
11/27/2001	US6322770 Indazole vitronectin receptor antagonist pharmaceuticals
11/27/2001	CA2217573C Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof
11/27/2001	CA2021912C Erythropoietin (epo) peptides and antibodies directed against these
11/22/2001	WO2001088540A1 Coated nanoparticles
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001087353A1 Preparations for diagnosing infection with helicobacter pylori
11/22/2001	WO2001087335A2 Method for selectively inhibiting ghrelin action
11/22/2001	WO2001018169A3 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases
11/22/2001	WO2001008660A3 Targeted fiberless radiative effectors
11/22/2001	US20010044584 In vivo delivery methods and compositions
11/22/2001	US20010044583 Gas filled liposomes and their use as ultrasonic contrast agents
11/22/2001	US20010043905 Method and compositions for detection and diagnosis of infectious diseases
11/22/2001	US20010042551 Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
11/22/2001	DE10023051A1 Production of fluorescein isothiocyanate-labelled sinistrin useful as reagent in non-invasive kidney diagnostics comprises reaction of activated sinistrin with fluorescein isothiocyanate
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/21/2001	EP1155073A1 Plastic moulding materials which can be detected by x-ray contrast
11/21/2001	EP1155023A1 Chelating compounds and their complexes with paramagnetic metals
11/21/2001	EP1154990A1 Phthalamide-lanthanide complexes for use as luminescent markers
11/21/2001	EP1154802A1 Method of measuring physiological function
11/21/2001	EP0876161B1 Contrast media
11/21/2001	EP0775117B1 Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells
11/21/2001	CN1074934C Metal complexes of polyaminoacids, and their utilization in diagnostic imaging
11/20/2001	US6321105 Method for diagnosing neurological, neurodegenerative and psychiatric diseases by magnetic resonance imaging using contrast agents with high magnetic susceptibility and extended plasma half life
11/20/2001	US6320040 Preparing novel nucleoside oligomers bearing pendant conjugate groups for incorporation into nucleic acids
11/20/2001	US6320016 Use of polycarbonates containing iodine phenyl carbonate for producing special shaped parts
11/20/2001	US6319952 Exposing the membrane to branched fatty acids or their salts, esters or amides which improve and enable the penetration and absorption of active ingredients through biomembranes
11/20/2001	US6319607 Purification of functionalized fluorescent nanocrystals
11/20/2001	US6319488 Polymethine with suitable photophysical and pharmacological properties, used in fluorescence and transillumination diagnostics
11/20/2001	US6319260 Method of endoscopic mucosal resection using mucopolysaccharide and local injection preparation
11/20/2001	CA2055594C Percutaneous lymphography
11/15/2001	WO2001085983A2 Methods for testing compounds useful for treating diabetic complications
11/15/2001	WO2001085906A2 Catalytically active peptides
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085756A2 Site-selective acyl transfer
11/15/2001	WO2001085219A2 Identification, diagnosis, and treatment of breast cancer
11/15/2001	WO2001085214A1 Radio-opaque polymeric compositions
11/15/2001	WO2001085013A2 Infrared thermography and methods of use
11/15/2001	WO2001085010A2 Medical optical imaging scanner using multiple wavelength simultaneous data acquisition for breast imaging
11/15/2001	WO2001017567A3 Improved container composition for diagnostic agents
11/15/2001	WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001	US20010041688 Methods and compositions for the regulation of vasoconstriction
11/15/2001	DE10000675C2 Lineardurchführung, Vorrichtung und Verfahren zur hochproduktiven Erzeugung von hoch kernspinpolarisiertem Helium-3 Gas Linear motion feedthrough, apparatus and method for highly productive generation of high kernspinpolarisiertem helium-3 gas
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2408399A1 Infrared thermography and methods of use
11/14/2001	EP1153129A1 Method of treating restenosis by antisense targeting of c-myc
11/14/2001	EP1153029A2 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
11/14/2001	EP1152696A2 Device and method for safe location and marking of a cavity and sentinel lymph nodes
11/14/2001	EP0652948B1 Development of a vector to target gene expression to the epidermis of transgenic animals
11/14/2001	EP0484369B1 Modified bioluminescent proteins and their use
11/14/2001	CN1074665C Method and medical agent for diagnosis and/or therapy of arthritis
11/13/2001	US6316434 Assay for emetic activity
11/13/2001	US6316409 Modified ligands of calcium-dependent binding proteins
11/13/2001	US6316403 Deactivation of factor ix for coagulation inhibition and antiischemic agents
11/13/2001	US6316215 Methods of cancer screening utilizing fluorescence detection techniques and selectable imager charge integration periods
11/13/2001	US6316003 Presenting to the cell an extracellular fusion protein consisting of a cargo moiety and a transport moiety and allowing transport moiety-dependent intracellular delivery of the fusion protein
11/13/2001	US6315995 Adding to blood inactive recombinant mutein comprising proteolytically inactive mutein of factor ix or ixa to inhibit clot formation, does not interfere with hemostasis when the blood is administered to a patient
11/13/2001	US6315981 Used for obtaining image of an internal region of humans
11/13/2001	US6315730 Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent
11/13/2001	US6315729 Ultrasonic diagnostic imaging with contrast agents
11/08/2001	WO2001083425A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	WO2001082976A2 Functional mri agents for cancer imaging
11/08/2001	WO2001082975A2 Membrane-permeant peptide complexes for medical imaging
11/08/2001	WO2001082974A2 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability
11/08/2001	WO2001082899A2 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
11/08/2001	WO2001082795A2 Magnetic resonance imaging agents for the delivery of therapeutic agents
11/08/2001	WO2001056582B1 Tracking gene expression and metabolic processes in subjects
11/08/2001	WO2001051094A8 Diagnostic method using a deuterated agent for imaging specific tissue
11/08/2001	WO2001041811A3 Carrier peptide and method for delivery of molecules into cells
11/08/2001	WO2000061194A3 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
11/08/2001	US20010039034 Method for labeling individual cells
11/08/2001	US20010038823 Microparticles, process for their production, and their use in ultrasound diagnosis
11/08/2001	DE10020376A1 Dynamische Marker Dynamic markers
11/08/2001	CA2407978A1 Functional mri agents for cancer imaging
11/08/2001	CA2407450A1 Magnetic resonance imaging agents for the delivery of therapeutic agents
11/08/2001	CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/08/2001	CA2405611A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/07/2001	EP1152061A1 Development of method for screening physiologically active pyrrole imidazole derivative
11/07/2001	EP1151997A1 Polychelants, their complexes with metal ions, their preparation and their uses
11/07/2001	EP1150943A1 Preparation of iodixanol
11/07/2001	EP0831934B1 Preparation and use of contrast agents
11/07/2001	EP0804161B1 Continuous method of grinding pharmaceutical substances
11/06/2001	US6312694 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
11/06/2001	US6312664 Biodegradable contrast media for MR imaging
11/06/2001	CA1341315C Targeted forms of methyltrithio antitumor agents
11/01/2001	WO2001081923A1 Dynamic superparamagnetic markers
11/01/2001	WO2001080632A1 Cell and nonhuman animal capable of amplifying hcv
11/01/2001	US20010036642 Antibodies specific for papillary fibroblasts as markers for skin quality

1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 354